Mysterious Fog in the US , Canada and UK: A dense, eerie fog with a "burning chemical-like smell" has spooked a good part of North America and parts of the United Kingdom and Canada. With social media amplifying all concerns, this phenomenon has sparked attention across all social media platforms. However, at the heart of this mysterious fog are a conjunction of natural events, social psychology, and environmental conditions that culminated in all the conspiracy theories and public health fears. Here's a closer look at the mysterious fog, its potential causes, and the societal response it has triggered.

Fog that Feeds Fear

The first reports of this "mysterious fog" came in from Florida where a resident said that they experienced respiratory symptoms, feverish warmth, and stomach cramps after contact with the fog. Similar stories started flooding social media, and within a day or two, a sinister force seemed to sweep across the United States, Canada, and parts of the UK. From Texas to Minnesota, people reported weird odors and health issues that they thought were linked to this bizarre atmospheric event.

Some witnesses were said to see "white particles" swirling through the air; theories ranged from a chemical attack or experimental weapon to drone-related chemical dispersals and references to historical military experiments, such as the infamous 1950s "Operation Sea-Spray."

Fuel to the fire were added when videos and posts, hundreds of thousands in number, began circulating on social media sites like TikTok and X (formerly Twitter) speculating on the origin of the fog. Hashtags like #ToxicFog went trending for days. Hysteria created a self-reinforcing loop in which every post spurred further scrutiny and fear.

Scientific Explanation of the Dense Mysterious Fog

1. What is Fog?

Fog is essentially a low-lying cloud formed when the air temperature cools to its dew point, causing water vapor to condense into tiny droplets or ice crystals. Several types of fog—advection fog, radiation fog, and valley fog—can form depending on conditions such as warm, moist air moving over cooler land or when temperatures plummet rapidly under clear skies.

2. Why the Chemical Smell?

Such chemical-like smell as reported during the occurrence of fog events is sometimes attributed to air pollution. It acts like a sponge, where it absorbs these pollutants, which include sulfur dioxide and nitrogen oxides, among others, that emit from industries. This mixture, therefore, leads to a stench that could be mistaken as unnatural or even toxic.

Also Read: Health Concerns Rise As US, Canada, and UK Come Under The Blanket Of Thick, Dense, Toxic Fog

3. What are the Health Concerns?

High moisture levels from fog can significantly exacerbate symptoms related to respiration, but especially in already predisposed asthmatics and allergy patients. The connection of these symptoms with actual fever, stomach cramps, and puffy eyes is too remote. Experts assume that the irritating effects of entrapped pollutants trapped in fog tend to affect more the eyes and throat rather than the rest of the body affected by some report.

Psychological Effects of Mass Panic Caused by Social Media

Social media amplified a natural weather event into a health epidemic. It made the personal experience of individuals become a cause for fear and speculation, a domino effect.

According to psychologists, this is a concept of selective perception, wherein once people's attention is drawn to environmental anomalies, they begin to notice them. This mirrors earlier panics, such as the Seattle windshield pitting panic of 1954. Then, atomic bomb testing caused fear in many and started to have people looking at their windshields for small marks that they had not seen before. Likewise, postings on the strangeness of the fog probably increased public awareness and suspicion, with people looking to attach unrelated symptoms to the phenomenon.

The fog hysteria shares a commonality with other instances of mass panic, such as the "drone sightings" of recent years or the Cold War-era fears of biological warfare.

Also Read: Mysterious Fog Is Making Americans Sick

These events underscore how fear can cloud judgment, especially when amplified by social media and sensationalist headlines. While historical cases, such as "Operation Sea-Spray," offer concrete evidence of the existence of unethical experiments, the jump from a natural weather condition to theories of chemical attacks exemplifies a more modern trend of connecting unrelated dots, all wonderfully seeded in distrust and anxiety.

Despite the swirling rumors, meteorologists and scientists are in agreement that the mysterious fog is not as alarming as it seems. It is well known that fog traps and amplifies pollutants, especially in urban and industrial regions. Moreover, winter months are the most conducive for fog formation, so its recent prevalence is unsurprising.

On the other hand, environmentalists advise that the fog should wake everyone up to increased levels of pollution. The reported odors and health irritations could be just symptoms of far deeper systemic issues like industrial emissions and lack of control over air quality.

The authorities must be transparent in their communication to combat misinformation and allay public fears. Governments and environmental agencies must provide timely updates on weather phenomena, air quality, and health risks. Initiatives like real-time pollutant tracking and public education campaigns can help demystify natural occurrences while addressing valid environmental concerns.

The mysterious Canada fog is a compelling case study in how environmental events intersect with psychology and societal dynamics. While rooted in natural phenomena, the fog became a vessel for collective fears, amplified by modern technology and historical anxieties.

In this information era where communication occurs at an almost lightning pace, the fog becomes a metaphor that reminds everyone about scientific literacy, environmental responsibility, and an effective balance when considering public concern. Whether perceived as a marvel of nature or as a tale that serves to teach, it left a very powerful mark in people's minds.

A popular over-the-counter eye drop has been recalled across the US over concerns that the product may not be sterile, raising the risk of contamination and potential eye infections.

Prestige Brands Holdings has voluntarily recalled 39,060 bottles of Clear Eyes Maximum Itchy Eye Relief, according to the FDA. The recall includes a specific lot of the product.

The recall is particularly important because eye drops are applied directly to the eyes, which means contaminated products can bypass some of the body's natural protective barriers.

Which Clear Eyes Eye Drops Are Recalled?

Consumers who have been using this brand's eye drop must check for the following details:

• Product: Clear Eyes Maximum Itchy Eye Relief
• Bottle size: 15 mL (0.5 fl oz)
• Lot: 2552A
• Expiration date: September 30, 2027
• NDC: 67172-999-01
• UPC: 6 78112 65920 3
• Quantity recalled: 39,060 bottles

The company initiated the voluntary recall on July 29, 2026, and the FDA classified it as a Class II recall on August 14.

A Class II recall means exposure to the affected product could cause medically reversible health consequences, although the likelihood of serious harm is considered remote.

Also read: UK Salmonella Outbreak May Be Linked to Imported Eggs: 1 Dead, 200+ Ill—How to Stay Safe

Why Is Contamination In Eye Drops A Serious Concern?

Eye drops are different from other medicines as they are intended to be strictly sterile at all times. The FDA notes that ophthalmic medicines pose a heightened risk because they could bypass some of the body's natural defences.

Contaminated eye drops can introduce microorganisms directly onto the eye and potentially cause infection.

Depending on the type and severity of contamination, an eye infection can cause symptoms ranging from redness and irritation to pain, discharge, vision changes and, in severe cases, serious damage to the eye. This is why sterility is a major safety requirement for ophthalmic products.

This particular recall is based on a potential contamination and lack of assurance of sterility. It does not mean that every bottle is contaminated or that everyone who used the product will develop an infection.

The FDA has not indicated that every user of the recalled product will experience adverse effects. However, consumers who have a recalled bottle should stop using it rather than taking the risk.

Also read: After FDA Crackdowns, Karnataka Launches QR Code To Report Food & Drug Safety Violations Instantly

What Should You Do If You Have The Recalled Eye Drops?

If you have the recalled bottle of eye drops, check the lot number and expiration date on the packaging. If your bottle matches the recalled product, stop using it.

Consumers should also follow the recall instructions for returning or disposing of the product and can contact a healthcare professional.

The FDA also advises people to stop using eye drops and seek medical advice if they develop eye pain, discharge, changes in vision or significant discomfort.

One Of Many Eye-Drop Recalls

The latest recall comes amid a broader series of eye-drop safety concerns in the US. In recent months, other eye-drop products have also been recalled over sterility concerns and potential contamination. For example, nearly 12 million cartons of certain Rohto Cooling Eye Drops were recalled in July because sterility could not be assured.

The FDA says it continues to monitor ophthalmic products through sampling and testing, because contaminated eye drops have previously been linked to infections and serious eye complications.

A US woman undergoing routine knee surgery at a Nashville hospital was left paralyzed following a medical mistake in which potassium was reportedly given instead of the intended anesthetic.

Speaking to the media, her daughter-in-law said that while the 72-year-old’s knee replacement went well, potassium administered during spinal anesthesia instead of bupivacaine has left her paralyzed.

“The joint replacement went wonderfully. Her knee is great. The rest of her is not,” daughter-in-law Kristina Dorton was quoted as saying by WSMV.com.

What Went Wrong During the Knee Surgery?

On August 14, her mother-in-law went in for a routine knee replacement at Ascension Saint Thomas Hospital Midtown. Everything appeared normal for the healthy 72-year-old until the surgical team realized that she had been given the wrong medicine during spinal anesthesia.

“It was supposed to be the anesthetic. It was supposed to be Bupivacaine, and it was potassium, and we don’t know what quantity,” Dorton said.

According to Dorton, when her mother-in-law woke up from surgery, she was sent to the intensive care unit. While the knee replacement was successful, her family is worried that she may never be able to feel her knee or any part of her lower body again.

“Currently, she has zero feeling, movement, or response to pain from her breastbone down. We don’t know what recovery looks like or if there is recovery,” Dorton said.

Four Patients Reportedly Impacted

According to media reports, the woman was not the only patient affected. An investigation found that as many as four patients were impacted by similar “events” involving the administration of the wrong medication at Ascension Saint Thomas Hospital Midtown.

“Our hearts are with the four patients and their families impacted by this event. On behalf of our leadership and care teams, I am deeply sorry for the harm caused to our patients,” Dr. Shubhada Jagasia, president and CEO of Ascension Saint Thomas Hospital’s Midtown, said in a statement.

However, hospital officials did not confirm whether the other patients also received potassium instead of the intended anesthetic, stating that they would not provide specific clinical details to protect patients’ privacy.

While Jagasia said the hospital is ensuring that affected patients have access to the resources and ongoing care they need, Dorton said treatment aimed at reversing her mother-in-law’s paralysis has not worked.

“This is life-changing. You don’t come out of this without some type of life-altering, catastrophic deficit,” Dorton said.

“We just are hoping that publicizing this gets some sort of genius somewhere that knows what to do… Time is of the essence here for recovery,” Dorton added.

When Can Potassium Turn Dangerous?

Potassium is an essential mineral that helps the body function. While it plays important roles in blood pressure regulation, bone health and kidney function, having too much potassium in the blood can lead to serious and potentially life-threatening problems.

Too much potassium in the blood is known as hyperkalemia. Severe hyperkalemia can affect the heart’s electrical activity and cause dangerous abnormal heart rhythms or cardiac arrest.

Potassium is also not used as an anesthetic agent. During medical care, potassium levels must be carefully managed because changes in this electrolyte can significantly affect heart and muscle function.

A personalized mRNA cancer vaccine developed by pharma giants Moderna and Merck has shown promise for patients with melanoma, a potentially deadly form of skin cancer, in a late-stage trial.

The vaccine, called intismeran autogene, or mRNA-4157/V940, is custom-made for each patient using the unique genetic blueprint of their tumor.

The Phase 3 results build on earlier Phase 2b findings and showed that the combination of intismeran and Keytruda reduced the risk of cancer recurrence or death by 49% and reduced the risk of distant cancer spread or death by 59% up to five years.

“These Phase 3 findings represent a pivotal moment for the field of cancer research. For many years, the idea of creating an mRNA treatment designed specifically for an individual patient's cancer was aspirational. We are now helping turn that vision into a reality,” said Stéphane Bancel, CEO of Moderna.

Trial Shows Longer Cancer-Free Survival

The Phase 3 INTerpath-001 trial met its primary endpoint of recurrence-free survival (RFS) and a key secondary endpoint of distant metastasis-free survival (DMFS).

Intismeran autogene in combination with Keytruda demonstrated statistically significant and clinically meaningful improvements in RFS and DMFS compared with Keytruda alone.

The findings were seen in patients with stage IIB, IIC, III, or IV cutaneous melanoma who had undergone complete surgical removal of their cancer and had not previously received systemic therapy.

The companies, however, aim to continue evaluation of other key secondary endpoints, including overall survival.

What Is Intismeran Autogene?

Intismeran autogene is an experimental "neoantigen therapy" that uses specific mutations in a patient’s tumor to train the immune system to recognize and fight cancer cells.

The treatment is designed using a patient’s tumor sample to identify the unique mutational signature, or “fingerprint,” of their cancer and generate an anti-tumor immune response.

Each therapy contains synthetic mRNA coding for up to 34 neoantigens and is tailored to the unique biology of an individual patient’s tumor.

After administration, the RNA-encoded neoantigen sequences are translated in the body and presented to the immune system, helping generate specific T-cell responses against cancer cells.

How Was the Phase 3 Trial Conducted?

• 1,137 patients with high-risk, resected stage IIB-IV melanoma took part in the trial.
• Participants were randomly assigned 2:1 to receive either:
• Intismeran autogene + Keytruda
• Keytruda alone
• Intismeran was given every three weeks for up to nine doses.
• Keytruda was given every six weeks for up to nine cycles, for about one year.
• The trial assessed the safety and effectiveness of the combination compared with Keytruda alone.

Were There Any Safety Concerns?

The safety profiles of intismeran autogene and Keytruda in the trial were consistent with those observed in previously reported studies of the combination. No new safety signals were observed.

“Intismeran in combination with pembrolizumab has the potential to establish a new treatment paradigm in the adjuvant melanoma setting, helping patients remain cancer-free for longer,” said Professor Georgina Long, the study’s principal investigator and medical director of Melanoma Institute Australia.

Long said the results “represent a landmark moment for adjuvant melanoma treatment.”